Tuesday, November 24, 2020 9:50:24 AM
"In this study we extended these studies to look at cell survival, maturation and functional integration in an in vivo rat model of rhodopsin-mutant retinitis pigmentosa causing blindness."
Not quite sure it justifies the entirely dishonest heading of this pumping PR from the pimp (s?) at PKTX:
"ProtoKinetix AAGP® Restores Vision in Blind Test Subjects"
https://www.businesswire.com/news/home/20200915005500/en/ProtoKinetix-AAGP%C2%AE-Restores-Vision-in-Blind-Test-Subjects
LOL.
That PR alone should result in prosecution and jail time for the crooks behind this evident scam. The man from Peoria would reasonably think "subjects" refers to people, not a bunch of tests in artificially manipulated rat cells.
It was blatant lying. Just what we have come to expect from the crooks behind PKTX.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM